(firstQuint)The Use of Metformin in Early Breast Cancer Patients Pre-Surgery.

 Patients will take metformin twice a day for 3 weeks before surgery.

 The hypothesis is that metformin will reduce cell proliferation rates (Ki67) and increase apoptoses (TUNEL)in tumor tissue.

 The study will collect and analyze pre- and post-treatment blood specimens for: - Serum glucose - Insulin levels - Estradiol - HOMA test - Glycosylated haemoglobin.

 The Use of Metformin in Early Breast Cancer Patients Pre-Surgery@highlight

The study will test metformin in patients with early breast cancer.

 Blood and tissue will be collected before and after the use of metformin.

